Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.

Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. Abstract Text:

Amit Kumar,Christopher P Cannon,Amit Kumar,Christopher P Cannon,Amit Kumar,Christopher P Cannon,

Lipid-lowering therapy with statins reduces the risk of cardiovascular events in patients with established coronary heart disease (CHD). Traditionally, statins were perceived to lower the long-term cardiovascular risk by reducing elevated low-density lipoprotein cholesterol (LCL-C). Recently, this benefit has been established for patients early after acute coronary syndrome (ACS). The benefit appears linked to reductions in both LDL-C and C-reactive protein (CRP) that is a marker of systemic inflammation. This paper will review the current state of evidence from key recent statin trials in ACS and percutaneous coronary intervention (PCI) and discuss their significance for clinical practice.

Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. Publishing Authors By Initials

A Kumar,CP Cannon,A Kumar,CP Cannon,A Kumar,CP Cannon,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of interventional cardiology

VOLUME: 20

Page Numbers: 447-57

Journal Abbreviation:

ISSN: 0896-4327

DAY: 28

MONTH: Dec

YEAR: 2007

Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8907826

Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.

AFFILIATION: UMass Marlborough Health System, Marlborough, Massachusetts, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Interv Cardiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention Related Publications

• A Na+ channel mutation linked to hypokalemic periodic paralysis exposes a proton-selective gating pore.
• Amino acid residues affecting drug pump function in Candida albicans--C. albicans drug pump function.
• Analogical reasoning in working memory: resources shared among relational integration, interference resolution, and maintenance.
• Aneurysmal bone cyst of the paediatric shoulder girdle: a case series and literature review.
• Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28.
• Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae.
• Cognitive errors, anxiety sensitivity, and anxiety control beliefs: their unique and specific associations with childhood anxiety symptoms.
• Cortical mapping of genotype-phenotype relationships in schizophrenia.
• Current trends in computational inference from mass spectrometry-based proteomics.
• Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: implications for receptor usage and pathogenicity.
• First recanalization of a coronary artery chronic total obstruction in an 11-year-old child with Kawasaki disease sequelae using the CROSSER catheter.
• Frances Ashcroft: 2007 Walter B. Cannon physiology in perspective lecture.
• Gender differences in aspirin use among adults with coronary heart disease in the United States.
• Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.
• Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.
• Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
• Lipid-independent Pleiotropic Effects of Statins in the Management of Acute Coronary Syndromes.
• Maintenance of AV synchrony in a small child utilizing two pacemakers and the triggered VVT mode: triggered pacing in small children.
• Mineral Trioxide Aggregate but not Light-cure Mineral Trioxide Aggregate Stimulated Mineralization.
• Predisaster trait anxiety and negative affect predict posttraumatic stress in youths after hurricane Katrina.
• Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia.
• Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
• Restoring federal commitment to basic nuclear medicine research.
• Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients.
• Self-report of attenuated psychotic experiences in a college population.
• Senate appropriators restore funding for basic nuclear medicine research at DOE.
• Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice.
• The association of race and ethnicity with disease expression in male US veterans with rheumatoid arthritis.
• The course of neurocognition and social functioning in individuals at ultra high risk for psychosis.
• The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects.